Nuvation Bio (NUVB) Total Liabilities (2020 - 2026)
Nuvation Bio (NUVB) posted quarterly Total Liabilities of $290.7 million for Q1 2026, up 298.03% year-over-year from $73.0 million in Q1 2025, and up 0.54% quarter-over-quarter from $289.1 million in Q4 2025.
Nuvation Bio (NUVB) Total Liabilities (2020 - 2026) Analysis & Trends
Nuvation Bio (NUVB) has reported Total Liabilities for 7 consecutive years, with $290.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Liabilities rose 298.03% year-over-year to $290.7 million; the TTM figure through Mar 2026 stood at $290.7 million (up 298.03% YoY), while the FY2025 annual figure was $289.1 million, up 276.25% from the prior year.
- Total Liabilities grew to $290.7 million in Q1 2026 per NUVB's latest filing, from $289.1 million in the prior quarter.
- Across five years, Total Liabilities topped out at $290.7 million in Q1 2026 and bottomed at $16.0 million in Q1 2023.
- Historically, Total Liabilities has averaged $93.5 million across 5 years, with a median of $28.2 million in 2022.
- Annual changes were most pronounced in 2022 — Total Liabilities plunged 43.41% — and 2024, when it surged 369.61%.
- Nuvation Bio's Total Liabilities stood at $17.1 million in 2022, then dropped by 4.12% to $16.4 million in 2023, then soared by 369.61% to $76.8 million in 2024, then jumped by 276.25% to $289.1 million in 2025, then climbed by 0.54% to $290.7 million in 2026.
- Business Quant data shows NUVB's Total Liabilities at $290.7 million in Q1 2026, $289.1 million in Q4 2025, and $275.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.62 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 1.72 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 4.00 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 7.02 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 10.03 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.20 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.35 Bn |
| 10 | Nuvation Bio | 2.16 Bn | 2.16 Bn | 30.78 Mn | 490.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 490.64 Mn |
| Mar 31, 2026 | 290.68 Mn |
| Dec 31, 2025 | 289.11 Mn |
| Sep 30, 2025 | 275.68 Mn |
| Jun 30, 2025 | 274.32 Mn |
| Mar 31, 2025 | 73.03 Mn |
| Dec 31, 2024 | 76.84 Mn |
| Sep 30, 2024 | 68.87 Mn |
| Jun 30, 2024 | 62.67 Mn |
| Mar 31, 2024 | 19.08 Mn |
| Dec 31, 2023 | 16.36 Mn |
| Sep 30, 2023 | 19.28 Mn |
| Jun 30, 2023 | 16.78 Mn |
| Mar 31, 2023 | 15.99 Mn |
| Dec 31, 2022 | 17.07 Mn |
| Sep 30, 2022 | 18.55 Mn |
| Jun 30, 2022 | 26.66 Mn |
| Mar 31, 2022 | 28.24 Mn |
| Dec 31, 2021 | 30.15 Mn |
| Sep 30, 2021 | 28.43 Mn |